Total Funding
25
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
208812
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
- Josh Disbrow: Co-Founder,Chairman & CEOPast Role: Arbor Pharmaceuticals, Vice President of Commercial Operations
Russ McMahen: VP of Research & DevelopmentPast Role: ZenithOptimedia, Team Member
About the Company
The Neos Therapeutics team is dedicated to creating high-quality products and partnering with pharmaceutical and consumer healthcare companies to address key medical needs.
Neos Therapeutics’ research and development (R&D) and fully integrated state of the art, FDA approved manufacturing facility is located in the Dallas/Fort Worth
area.
